US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 3.640
- +0.100+2.82%
Close Dec 24 13:00 ET
- 3.560
- -0.080-2.20%
Post 16:37 ET
177.75MMarket Cap-1.99P/E (TTM)
3.650High3.410Low503.13KVolume3.520Open3.540Pre Close1.78MTurnover1.49%Turnover RatioLossP/E (Static)48.83MShares4.50052wk High-14.11P/B122.87MFloat Cap1.38052wk Low--Dividend TTM33.75MShs Float105.000Historical High--Div YieldTTM6.78%Amplitude1.300Historical Low3.531Avg Price1Lot Size
About Checkpoint Therapeutics Company
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.
Company Profile
SymbolCKPT
Company NameCheckpoint Therapeutics
Listing DateJun 26, 2017
Founded2014
CEOMr. James F. Oliviero, III
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address95 Sawyer Road,Suite 110
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-652-4500
Websitehttp://www.checkpointtx.com
Company Executives
- Name
- Position
- Salary
- James F. Oliviero, III
- Director, President and Chief Executive Officer
- 1.64M
- Garrett Gray
- Chief Financial Officer, Corporate Secretary and Treasurer
- 712.88K
- Michael S. Weiss
- Chairman of the Board
- 110.00K
- Dr. Lindsay A. Rosenwald, M.D.
- Director
- 100.00K
- Dr. Amit Sharma, F.A.C.P.
- Independent Director
- --
- Barry Salzman
- Independent Director
- 100.00K
- Neil Herskowitz
- Independent Director
- 110.00K
- Christian Bechon
- Independent Director
- 100.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data